Pherecydes Pharma secures DGA funding for evaluating the use of bacteriophages on infected burns.
The French Government Defence procurement agency invests €900,000 towards Pherecydes Pharma managed €1.2-million project, involving several university and military laboratories.
"Tough Microbe Infections " Forum - January 2012
Pherecydes Pharma is attending the Forum coorganised by PHAG ESPOIRS and LE LIEN associations, as well as their partners, Narbonne Hospital and City, on January 25, 2012 in Narbonne - France, at 9h15, in Le Théatre.
Pherecydes goes in quest of € 3 million
Biotech Finance press details the purpose of this investiment targeting the set up of a phage bioproduction unit and testing of 2 therapeutic products in human clinical trials.
Bio-Entrepreneur Forum 2011: a harvest of business meetings
Meeting the Belgian biotech companies at the 2011 Forum Bio-Entrepreneurs held in the Bourse de Commerce de Paris, December 6, 2011.
Phage Industry News Letter
 |
Phages are about to become essential for biotechnology developments in industrialized countries. Used mainly in the former soviet block from the early 30’s to nowadays, bacteriophages are now gaining interest into western countries. Antibiotic and antiseptic failures against a wide range of bacterial strains certainly opens the door to such products.
As a new actor in this world, we were puzzled by the lack of information related to our nascent industry and decided to create The Phage Industry News Letter, dedicated to bacteriophages and their practical use.
|
Each quarterly edition will deal with a domain using full or parts of living or dead phages. Topics will address diagnostic, therapy, disinfection, animal care, nanowires… Voluntarily focused on industrial applications, the minute will enable companies to have their say about technological data, markets to be conquered or strategic events.
Infini'click : Web agency